神经递质失衡,谷氨耗尽和伴随的敏感性增加导致帕金森病
Su Yan1, Bingfang Duan1, Yuanhao Li1
1Department of Radiology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.
NeuroImage. Clinical
|January 31, 2025
概括
帕金森病 (PD) 涉及大脑GABA和谷氨 (GSH) 的减少,以及铁沉积的增加. 这些代谢变化,包括神经递质和抗氧化剂水平,与PD症状和进展有关.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 放射学 放射学是一门学科.
背景情况:
- 帕金森病 (PD) 的病理生理学涉及神经传递,铁的积累和氧化应激.
- 关键代谢物如神经递质和谷氨 (GSH) 在PD中未得到充分研究.
- 磁性敏感性也是PD的相关标志物.
研究的目的:
- 在PD患者中研究神经递质,GSH和磁性敏感性同时发生的变化.
- 探索这些生物标志物与临床症状之间的关系.
主要方法:
- 在60名PD患者和47名健康对照中使用MEGA-PRESS和多回声梯度回声MRI序列.
- 使用磁共振光谱学量化中脑GABA和谷氨酸+谷氨酸,以及条状GSH.
- 评估了磁性敏感性和与临床数据相关的代谢物水平.
主要成果:
- 患有PD的患者显示中脑下部的GABA和条状GSH水平.
- 在PD患者的黑色物质中观察到磁性敏感性增加.
- 在PD中发现了GSH,GABA和易感性之间的破坏性关联.
结论:
- PD的特征是同时减少GABA和GSH.
- 铁沉积,由增加的敏感性表明,也是一个关键的特征.
- 这些代谢变化为PD病原体提供了洞察力.
相关概念视频
Parkinson's Disease: Treatment
192
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
192
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Excitatory and Inhibitory Effects of Neurotransmitters
9.7K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.7K
Role of Neurotransmitters in Memory
399
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
399


